Literature DB >> 16115228

The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study.

N Akpolat1, S Yahsi, A Godekmerdan, M Yalniz, K Demirbag.   

Abstract

AIMS: To investigate the value of alpha-smooth muscle actin (alpha-SMA), an indicator of stellate cell activation, in predicting fibrosis in chronic hepatitis B (CHB) patients. METHODS AND
RESULTS: The liver biopsy specimens of 30 patients with a clinical diagnosis of CHB were obtained before treatment and scored by Knodell's histological activity index. The specimens were then immunohistochemically stained with alpha-SMA and semiquantitatively evaluated. Fibrosis and the immunoreactivity of alpha-SMA in the periportal, perisinusoidal and pericentral areas were compared. Fibrosis and necroinflammatory activity in CHB patients were significantly correlated (P =0.022). Furthermore, the degree of alpha-SMA expression and the scores of fibrosis (in periportal, perisinusoidal and pericentral areas) were highly correlated (P =0.000, 0.001, 0.000, respectively).
CONCLUSIONS: In liver biopsy samples, alpha-SMA may prove to be a valuable marker in the evaluation of stellate cell activation and fibrosis progression and an early indicator of the development of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115228     DOI: 10.1111/j.1365-2559.2005.02226.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  20 in total

1.  Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.

Authors:  Maria Eduarda Rocha de França; Sura Wanessa Santos Rocha; Wilma Helena Oliveira; Laise Aline Santos; Anne Gabrielle Vasconcelos de Oliveira; Karla Patrícia Sousa Barbosa; Ana Karolina Santana Nunes; Gabriel Barros Rodrigues; Deniele Bezerra Lós; Christina Alves Peixoto
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

2.  Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies.

Authors:  Mary D Le; Elena Enbom; Peter K Traum; Valentina Medici; Charles H Halsted; Samuel W French
Journal:  Exp Mol Pathol       Date:  2013-07-23       Impact factor: 3.362

3.  Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice.

Authors:  Lung-Yi Lee; Ulrike A Köhler; Li Zhang; Drew Roenneburg; Sabine Werner; Jeffrey A Johnson; David P Foley
Journal:  Toxicol Sci       Date:  2014-10-06       Impact factor: 4.849

4.  Therapeutic effects of vitamin A on experimental cholestatic rats with hepatic fibrosis.

Authors:  Ken-ichi Murakami; Tatsuru Kaji; Ryuichi Shimono; Yoshihiro Hayashida; Hiroshi Matsufuji; Shinichiro Tsuyama; Rie Maezono; Ken-ichiro Kosai; Hideo Takamatsu
Journal:  Pediatr Surg Int       Date:  2011-02-03       Impact factor: 1.827

5.  Genistein improves schistosomiasis liver granuloma and fibrosis via dampening NF-kB signaling in mice.

Authors:  Chunpeng Wan; Fen Jin; Youqin Du; Kang Yang; Liangliang Yao; Zhigang Mei; Weifeng Huang
Journal:  Parasitol Res       Date:  2017-02-03       Impact factor: 2.289

6.  Chinese medicinal herbs in treating model rats with hepatic fibrosis.

Authors:  Yun-Xiao Zhou; Jiu Chen; Jian-Ping Li; Yan-Li Wang; Xiao-Dong Jin
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-12-30

Review 7.  The origin of fibroblasts and mechanism of cardiac fibrosis.

Authors:  Guido Krenning; Elisabeth M Zeisberg; Raghu Kalluri
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

8.  Exposure to fine airborne particulate matters induces hepatic fibrosis in murine models.

Authors:  Ze Zheng; Xuebao Zhang; Jiemei Wang; Aditya Dandekar; Hyunbae Kim; Yining Qiu; Xiaohua Xu; Yuqi Cui; Aixia Wang; Lung Chi Chen; Sanjay Rajagopalan; Qinghua Sun; Kezhong Zhang
Journal:  J Hepatol       Date:  2015-07-26       Impact factor: 25.083

9.  miR-200b is involved in intestinal fibrosis of Crohn's disease.

Authors:  Yingwei Chen; Wensong Ge; Leiming Xu; Chunying Qu; Mingjie Zhu; Wenzhu Zhang; Yongtao Xiao
Journal:  Int J Mol Med       Date:  2012-01-23       Impact factor: 4.101

10.  MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU Tablet.

Authors:  Qi Wang; Hongbo Du; Min Li; Yue Li; Shunai Liu; Ping Gao; Xiaoli Zhang; Jun Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.